Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73)

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 676-683

  Resta, Regina ^a,b   Hooker, Scott W ^a   Laurent, Aletha B ^a   Rahman, S M Jamshedur ^a   Franklin, Melissa ^a,b   Knudsen, Thomas B ^c   Nadon, Nancy L ^d   Thompson, Linda F ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF TULSA   (United States)

Author keywords

5' nucleotidase; adenosine deaminase; lymphocyte; P1 purinergic receptors; severe combined immunodeficiency

Indexed keywords

ADENOSINE DEAMINASE; NUCLEOTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE EXPRESSION REGULATION; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PURINE METABOLISM; SCID MOUSE; TRANSGENIC MOUSE;

EID: 0031025034     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119211     Document Type: Article

References (40)

1. Ma, D.D.F., T.A. Sylwestrowicz, S. Granger, M. Massaia, R. Franks, G. Janossy, and A.V. Hoffbrand. 1982. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. J. Immunol. 129:1430-1435.
2. Chechik, B.E., W.P. Schrader, and J. Minowada. 1981. An immunomorphologic study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines. J. Immunol. 126:1003-1007.
3. Hershfield, M.S., and B.S. Mitchell. 1995. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. Hum. Mol. Genet. 4:1725-1768.
4. Hirschhorn, R. 1995. Adenosine deaminase deficiency: molecular basis and recent developments. Clin. Immunol. Immunopathol. 76:S219-S227.
5. Hershfield, M.S., N.M. Kredich, D.R. Ownby, and R. Buckley. 1979. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine in adenosine deaminase-deficient patients. J. Clin. Invest. 63:807-811.
6. Migchielsen, A.A.J., M.L. Breuer, M.A. van Roon, H. te Riele, C. Zurcher, F. Ossendorp, S. Toutain, M.S. Hershfield, A. Berns, and D. Valerio. 1995. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat. Genet. 10:279-287.
7. Blackburn, M.R., S.K. Datta, M. Wakamiya, B.S. Vartabedian, and R.E. Kellems. 1996. Metabolic and immunologic consequences of limited adenosine deaminase expression in mice. J. Biol. Chem. 271:15203-15210.
8. Ratter, F., M. Germer, T. Fischbach, K. Schulze-Osthoff, M.E. Peter, W. Dröge, P.H. Krammer, and V. Lehmann. 1996. S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. Int. Immunol. 8:1139-1147.
9. Kizaki, H., H. Shimada, F. Ohsaka, and T. Sakurada. 1988. Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes. J. Immunol. 141:1652-1657.
10. Kizaki, H., K. Suzuki, T. Tadakuma, and Y. Ishimura. 1990. Adenosine receptor-mediated accumulation of cyclic AMP-induced T lymphocyte death through internucleosomal DNA cleavage. J. Biol. Chem. 265:5280-5284.
11. McConkey, D.J., S. Orrenius, and M. Jondal. 1990. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 145:1227-1230.
12. Lalli, E., P. Sassone-Corsi, and R. Ceredig. 1996. Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J. 15:528-537.
13. Widlin, R.S., A.M. Garvin, S. Pawar, D.B. Lewis, K.M. Abraham, K.A. Forbush, S.F. Ziegler, J.M. Allen, and R.M. Perlmutter. 1991. Developmental regulation of lck gene expression in T lymphocytes. J. Exp. Med. 173:383-393.
14. Misumi, Y., S. Ogata, K. Ohkubo, S. Hirose, and Y. Ikehara. 1990. Primary structure of human placental 5′-nucleotidase and identification of the glycolipid anchor in the mature form. Eur. J. Biochem. 191:563-569.
15. Chaffin, K.E., C.R. Beals, T.M. Wilkie, K.A. Forbush, M.I. Simon, and R.M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821-3829.
16. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 497 pp.
17. Fox, R.I., L.F. Thompson, and J.R. Huddlestone. 1981. T cells express T-lymphocyte associated antigens. J. Immunol. 126:2062-2063.
18. Thompson, L.F., J.M. Ruedi, A. Glass, G. Moldenhauer, P. Moller, M.G. Low, M.R. Klemens, M. Massaia, and A.H. Lucas. 1990. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositolanchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens. 35:9-19.
19. Dorken, B., P. Moller, A. Pezzutto, R. Schwartz-Albiez, and G. Moldenhauer. 1989. B cell antigens: CD73. In Leucocyte Typing IV: white cell differentiation antigens. W. Knapp, et al. editors. Oxford University Press, New York. 102-104.
20. Thompson, L.F., G.R. Boss, H.L. Spiegelberg, I.V. Jansen, R.D. O'Connor, T.A. Waldmann, R.N. Hamburger, and J.E. Seegmiller. 1979. Ecto-5′-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J. Immunol. 123:2475-2478.
21. Kisielow, P., H. Bluthmann, U.D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T cell receptor transgenic mice involves deletion of non-mature CD4+8-thymocytes. Nature (Lond.). 333:742-746.
22. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
23. Blackburn, M.R., X. Gao, M.J. Airhart, R.G. Skalko, L.F. Thompson, and T.B. Knudsen. 1992. Adenosine levels in the postimplantation mouse uterus: quantitation by HPLC-fluorometric detection and spatiotemporal regulation by 5′-nucleotidase and adenosine deaminase. Dev. Dyn. 194:155-168.
24. Knudsen, T.B., R.S. Winters, S.K. Otey, M.R. Blackburn, M.J. Airhart, J.K. Church, and R.G. Skalko. 1992. Effecft of (R)-Deoxycoformycin (Pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology. 45:91-103.
25. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
26. Widnell, C.C., Y. Schneider, B. Pierre, P. Baudhuin, and A. Trouet. 1982. Evidence for a continual exchange of 5′-nucleotidase between the cell surface and cytoplasmic membranes in cultured rat fibroblasts. Cell. 28:61-70.
27. Herman, A., J.W. Kappler, P. Marrack, and A.M. Pullen. 1991. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
28. Stehle, J.H., S.A. Rivkees, J.J. Lee, D.R. Weaver, J.D. Deeds, and S.M. Reppert. 1992. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol. Endocrinol. 6:384-393.
29. 2b receptor. Mol. Pharmacol. 47:1126-1132.
30. Jiang, H., N.K. Puffinbarger, R. Resta, and L.F. Thompson. 1996. Adenosine receptor expression in developing murine thymus. FASEB J. 10:A1047 (Abstr.)
31. Palmer, T.M., and G.L. Stiles. 1995. Review: Neurotransmitter receptors VII: adenosine receptors. Neuropharmacology. 34:683-694.
32. Bursch, W., S. Paffe, B. Putz, G. Barthel, and R. Schulte-Hermann. 1990. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (Lond.). 11:847-853.
33. Thompson, L.F. 1985. Ecto-5′-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells. J. Immunol. 134:3794-3797.
34. Snyder, F.F., and T. Lukey. 1980. Purine ribonucleoside and deoxyribonucleoside metabolism in thymocytes. Adv. Exp. Med. Biol. 122B:259-264.
35. Seto, S., C.J. Carrera, M. Kubota, D.B. Wasson, and D.A. Carson. 1985. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest. 75:377-383.
36. Hershfield, M.S. 1979. Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2-deoxyadenosine and adenine arabinoside. J. Biol. Chem. 254:22-25.
37. Mitchell, B.S., E. Mejias, P.E. Daddona, and W.N. Kelley. 1978. Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T cells. Proc. Natl. Acad. Sci. USA. 75:5011-5014.
38. Ullman, B., L.J. Gudas, A. Cohen, and D.W. Martin, Jr. 1978. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell. 14:365-375.
39. Hirschhorn, R., V. Roegner-Maniscalco, and L. Kuritsky. 1981. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J. Clin. Invest. 68:1387-1393.
40. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29:331-346.